Navigation Links
GlobalCare Clinical Trials, Ltd Announces Company Expansion Into Latin America
Date:3/9/2011

CHICAGO, March 9, 2011 /PRNewswire/ -- GlobalCare Clinical Trials, Ltd, (GlobalCare) today announced its expansion into Latin America. GlobalCare provides selected clinical study visits at convenient locations – such as in the home or alternate settings – for study patients to support phase I-IV trials in a variety of therapeutic areas, genomics and personalized medicine in all age groups. GlobalCare's patient-centric service model provides faster patient recruitment, better protocol compliance and higher retention rates, while helping to decrease the cycle of time to biopharmaceutical development and speed delivery of life-enhancing products to market for the benefit of patients worldwide.

Regulatory-compliant services provided by GlobalCare include: global project management; study drug administration; blood and other biologic sample collection; clinical assessments; patient training and education; device management; source documentation; and data collection. In addition, the company offers central and local out-patient pharmacy services including storage and distribution, compounding and dispensing, cold chain logistics, and sourcing of commercial products and devices.

Serving the Globe

GlobalCare provides services in over 20 countries and maintains a centrally managed network of multilingual country coordinators who are trained and certified on Good Clinical Practice/International Conference on Harmonization (GCP/ICH) guidelines and have in-depth knowledge of local medical practices and country cultural attitudes. The network is augmented by an extensive pool of over 20,000 qualified local traveling physicians and nurses in the United States, Canada, Australia, Europe, Israel, and now Latin America. GlobalCare's model enables patients to participate in clinical trials regardless of study duration; frequency of visits; disease state; distance to site; and/or family, work or community commitments by conducting study vis
'/>"/>

SOURCE GlobalCare Clinical Trials, Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
2. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
3. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
4. Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members
5. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
6. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
7. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
8. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
9. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
10. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
11. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 Pittcon 2015, the ... Spectroscopy, ended on March 12, in New Orleans with ... million as estimated by the New Orleans Convention and ... 14,200 conferees and exhibitor personnel. Those who attended ... conferee number. For the third year, the co-location of ...
(Date:3/31/2015)...  Sonoa Health, a health tech startup based in ... world-first consumer health portal, Health&, which brings together data ... more. Today, the Company appointed respected investment ... brings to the table more than 18-years experience in ... closely with the biggest names in Silicon Valley in ...
(Date:3/31/2015)...  Bayer HealthCare (Bayer) has expanded its collaboration ... Technology (MIT) and Harvard University to include cardiovascular ... new part of the alliance is to leverage ... cardiovascular therapies. "We are excited to ... the area of cardiovascular genomics to discover genes ...
(Date:3/31/2015)... Pa. , March 31, 2015   ... by integrating Mapi,s Medical Affairs and global Risk ... from a previously announced acquisition . ... operations are conducted by a global team that ... that have decades of experience in navigating complex ...
Breaking Biology Technology:Pittcon 2015 Hits the Big Easy in a Big Way 2Pittcon 2015 Hits the Big Easy in a Big Way 3Pittcon 2015 Hits the Big Easy in a Big Way 4Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3
... of Wisconsin's neighbors has reaffirmed its support for stem ... in Wisconsin. , ,Illinois Gov. Rod Blagojevich last week ... funds to support stem cell research. The announcement makes ... stem cell research after New Jersey, California and Connecticut. ...
... be like without a cold war and arms race? For ... security is the new battleground with a steady escalation of ... little iPods everyone is carrying around in their pockets. With ... too easily blows a hole below the waterline of many ...
... - A group of business and technology leaders ... million in pledged state funds for the Biomedical ... between academic researchers and private industry in southeastern Wisconsin. ... Committee by a margin of 15-1, and endorsed by ...
Cached Biology Technology:Illinois stem cell funding could aid issue's visibility 2Info Security: Taking a page from the 1950s 2Info Security: Taking a page from the 1950s 3Budget axe could cut SE Wisconsin tech alliance funding 2Budget axe could cut SE Wisconsin tech alliance funding 3
(Date:3/31/2015)...  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ("Elephant ... Defined Network Architecture (ET Software DNA® 2.0) platforms and ... $20.4 million for the year ended December 31, 2014 ... year ended December 31, 2013. At ... its multi-year transition away from its legacy landline business ...
(Date:3/31/2015)... 2015   Guidepoint , a leading global research ... Pain Management TRACKER, part of the Guidepoint TRACKER ... the medical device and therapeutics markets. The Post-Surgical Pain ... volumes, market share, and adoption rates across three major ... surgery. The Post-Surgical Pain Management TRACKER will ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... female meerkats subject their subordinates to escalating aggression and ... as a result infertile, a new study finds. , ... of her pregnancy, the dominant female in a meerkat ... for an average of three weeks at a time. ...
... A multi-institutional team of researchers has found that people with ... the brain responsible for voluntary movement and these signals can ... computer and converted into actions -- enabling a paralyzed patient ... 2006 issue of Nature, the researchers present the first published ...
... who - 10 years ago - created the cloned ... of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference in Boston, ... the world's leading scientists will discuss a variety of ... that is being hailed as the next revolution in ...
Cached Biology News:Dominant meerkats render rivals infertile 2Brain-computer link lets paralyzed patients convert thoughts into actions 2Brain-computer link lets paralyzed patients convert thoughts into actions 3Brain-computer link lets paralyzed patients convert thoughts into actions 4Brain-computer link lets paralyzed patients convert thoughts into actions 5Ten years later, Dolly is still making headlines 2
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
Rabbit polyclonal to EDG2 ( Abpromise for all tested applications). entrezGeneID: 1902 SwissProtID: Q92633...
... Synthetic peptide derived from the internal region ... Specific for the internal region of ... identifies the target band at ~590 kDa. ... secreted media from primary tracheobranchial epithelial cultures ...
...
Biology Products: